NK9 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Neuren Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 10.4 EUR 5.58% Market Closed

Market Cap: €1.3B

	Neuren Pharmaceuticals Ltd F:NK9	AU
	China Everbright Bank Co Ltd HKEX:6818	CN
I	Infratil Ltd ASX:IFT	NZ
G	Gaming and Leisure Properties Inc F:2GL	US
A	Autogrill SpA MIL:AGL	IT
E	Enwave Corp OTC:NWVCF	CA
V	voestalpine AG DUS:VAS	AT
	Lenovo Group Ltd HKEX:992	CN

Profitability Summary

Neuren Pharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Exceptional Operating Margin

45%

Strong 3Y Average Operating Margin

75%

Declining Operating Margin

70% > 45%

Exceptional Net Margin

40%

Strong 3Y Average Net Margin

60%

Declining Net Margin

69% > 40%

Exceptional Free Cash Flow Margin

163%

Strong 3Y Average Free Cash Flow Margin

71%

Free Cash Flow Margin is Increasing

68% > 163%

Low ROE

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

821%

Declining ROIC

968% > 23%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.